Hepatology International

Title Publication Date Language Citations
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update2015/11/13English1,693
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update2017/06/15English1,339
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update2012/05/17English753
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma2010/03/18English740
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update2008/05/10English669
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)2008/11/20English604
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 20142014/09/26English468
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update2019/06/06English442
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease2020/10/01English391
Goals and targets for personalized therapy for HCC2019/01/01English315
Role of free radicals in liver diseases2009/11/26English242
The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases2010/10/21English227
CSH guidelines for the diagnosis and treatment of drug-induced liver injury2017/04/12English187
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)2020/07/04English187
The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B2008/11/26English174
APASL consensus statements and recommendation on treatment of hepatitis C2016/04/29English164
Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease2010/08/12English152
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?2021/02/01English142
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update2016/10/06English140
Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg2017/05/26English134
Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis2018/06/07English132
Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models2017/08/30English131
Immune and inflammatory pathways in NASH2013/08/30English131
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review2007/12/29English125
Cirrhotic cardiomyopathy2008/11/11English121
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment2007/09/11English120
Albumin in chronic liver disease: structure, functions and therapeutic implications2015/09/29English119
Updates in the pathogenesis, diagnosis and management of ectopic varices2008/05/31English118
APASL consensus statements and management algorithms for hepatitis C virus infection2012/03/01English116
Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients2012/03/23English115